(2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid
C16H22N4O4 — CID 97186887
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid
(2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid (PubChem CID 97186887) has the molecular formula C16H22N4O4 and a molecular weight of 334.38 g/mol. Its IUPAC name is (2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid.
Molecular Properties
| Compound Name | (2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid |
|---|---|
| PubChem CID | 97186887 |
| Molecular Formula | C16H22N4O4 |
| Molecular Weight | 334.38 g/mol |
| Exact Mass | 334.16 |
| IUPAC Name | (2S)-2-(2-ethoxy-3-pyridinyl)-2-[methyl-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]amino]acetic acid |
| SMILES | CCOc1ncccc1[C@@H](C(=O)O)N(C)Cc1nc(C(C)C)no1 |
| InChI | InChI=1S/C16H22N4O4/c1-5-23-15-11(7-6-8-17-15)13(16(21)22)20(4)9-12-18-14(10(2)3)19-24-12/h6-8,10,13H,5,9H2,1-4H3,(H,21,22)/t13-/m0/s1 |
| InChIKey | SSDWNWAVKUAVIE-ZDUSSCGKSA-N |
| XLogP | 2.24 |
| TPSA | 101.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 334.38 |
| LogP ≤ 5 | 2.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 97186887 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.